Ring-modified proline short peptide compound and use thereof

US12116367B2 · kind B2 · utility

Assignee

• FUJIAN AKEYLINK BIOTECHNOLOGY CO., LTD. · CN

Inventors

• Shuhui CHEN · Shanghai, CN
• Yaxun YANG · Shanghai, CN
• Jianchen ZHANG · Shanghai, CN
• Peng Li · New York, US
• Haiying He · Shanghai, CN
• Zheng Wang · 安丰镇, CN
• Jian Li · Shanghai, CN

Key dates

• Filing date: Apr 25, 2023
• Grant date: Oct 15, 2024
• Expiry date: Apr 25, 2043

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07K1/003
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Disclosed are a ring-modified proline short peptide compound and the use thereof, and specifically disclosed is a compound represented by formula (X) or a pharmaceutically acceptable salt thereof.